Heron Therapeutics, Inc. (NASDAQ: HRTX)
$1.5700
-0.0300 ( -0.63% ) 322.0K
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Market Data
Open
$1.5700
Previous close
$1.6000
Volume
322.0K
Market cap
$243.35M
Day range
$1.5550 - $1.6250
52 week range
$1.0400 - $3.9300
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 8-k | 8K-related | 12 | Dec 23, 2024 |
| 8-k | 8K-related | 11 | Dec 03, 2024 |
| 10-q | Quarterly Reports | 61 | Nov 12, 2024 |
| 8-k | 8K-related | 12 | Nov 12, 2024 |
| 4 | Insider transactions | 1 | Nov 06, 2024 |
| 3 | Insider transactions | 2 | Nov 05, 2024 |
| 8-k | 8K-related | 12 | Nov 04, 2024 |
| 4 | Insider transactions | 1 | Oct 21, 2024 |
| 4 | Insider transactions | 1 | Oct 21, 2024 |
| 4 | Insider transactions | 1 | Oct 21, 2024 |